Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette–Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer

INTRODUCTION: The recommended treatment for intermediate and high-risk nonmuscle invasive bladder cancer (NMIBC) is adjuvant intravesical bacillus Calmette–Guerin (BCG) instillation. However, up to 50% experience tumor recurrences even after adjuvant BCG, and many patients develop local or systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Thyavihally, Yuvaraja B., Waigankar, Santosh S., Dev, Preetham, Asari, Ashish, Pednekar, Abhinav P., Athikari, Nevitha, Raut, Abhijit, Khandekar, Archan, Badlani, Naresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525474/
https://www.ncbi.nlm.nih.gov/pubmed/34759657
http://dx.doi.org/10.4103/UA.UA_139_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525474/
https://www.ncbi.nlm.nih.gov/pubmed/34759657
http://dx.doi.org/10.4103/UA.UA_139_20

Ejemplares similares